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Abstract
Background. Only few direct comparative studies evaluated the effectiveness of telemedicine-guided home blood 
pressure (tele-HBPM) compared to 24h ambulatory blood pressure monitoring (ABPM) in assessing blood pressure 
(BP) and BP control.
Material and methods. This prospective clinical trial included patients with arterial hypertension, with (n = 23) and 
without (n = 18) chronic kidney disease and normal volunteers (n = 16). All subjects underwent with a 1-month 
interval twice one-week of BP monitoring with office BP (3 measurements at 2 visits), 24 h-ABPM and tele-HBPM 
during 7 consecutive days.
Results. Mean (SD) BP levels were 128/77 [19/11] mm Hg and 126/75 [14/9] mm Hg for tele-HBPM, 129/78 
[17/11] mm Hg and 127/75 [14/9] mm Hg for daytime-ABPM, and 133/77 [23/12] mm Hg and 130/74 [17/11] 
mm Hg for office BP, all respectively at the first and the second measurement periods. Blood pressure and BP control 
were comparable between the two out-of-office techniques.
Conclusion. Both out-of-office techniques (tele-HBPM and 24h-ABPM) show good agreement for systolic as well 
as diastolic BP, and are equally effective in assessing BP and BP control, explicitly during daytime. 
Key words: arterial hypertension; office blood pressure; ambulatory blood pressure; home blood pressure; blood 
pressure telemonitoring; chronic kidney disease
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Introduction
Office blood pressure (BP) measurement is still 
considered as the reference method for screening, 
diagnosis and management of hypertension. How-
ever, office BP may be unrepresentative of the actual 
BP due to the white-coat and masked hypertension 
phenomena [1]. In patients with chronic kidney 
disease (CKD), office BP values often seem to be 
inaccurate [2]. Moreover out-of-office BP monitor-
ing is superior to office measurements in predicting 
organ damage [3, 4], and is therefore considered 
complementary to office BP measurements [1]. Am-
bulatory BP monitoring (ABPM) is the reference 
for out-of-office BP since it provides additional in-
formation on night-time BP compared to home BP 
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monitoring (HBPM). However, there are no strong 
data to support superiority of either out-of-office 
BP measurement for hard cardiovascular or renal 
endpoints [5]. Although some discrepancy exists in 
the literature, the ESH/ESC proposes the same cut-
off values for HBPM as for daytime-ABPM; and 
advices that abnormal values on HBPM should be 
confirmed by ABPM [1]. According to recent papers 
HBPM should have a primary role in the diagnosis, 
treatment and follow-up of hypertensive patients [3]. 
However, the data obtained by conventional 
HBPM are often incomplete, inaccurate, illegible or 
unreliable if recorded by patients in handwritten log-
books [6]. To overcome these disadvantages the use of 
telemonitoring has been introduced. Telemonitoring 
consists of an automatic remote data transmission 
from the point of care to the doctor’s office; BP values 
obtained by HBPM are transferred to a computer 
through a telephone line, a modem or the Internet [7]. 
Few studies directly compared HBPM and 
ABPM, and only two investigators used telemedi-
cine-guided home blood pressure (tele-HBPM) [8] 
(Tab. 1), Some studies did not find a significant 
difference between HBP and day-time-ABP, while 
others found significant higher or lower HBP than 
daytime-ABP-values [9–24]. Both studies with tele-
HBPM showed a significant difference, but in the 
opposite direction [18, 21]. 
The main objective of this study was to evaluate 
the effectiveness of tele-HBPM and 24h-ABPM in 
assessing BP and BP control in patients with arterial 
hypertension with and without CKD and in normo-
tensive volunteers.
Material and methods
Study design
All subjects underwent with a 1-month interval 
twice one-week of BP monitoring. At the first visit 
(visit 1 — day 1) baseline characteristics were col-
lected (age, sex, race, weight, length, number and 
type of antihypertensive medication), office BP was 
measured and patients were asked to fill in 3 ques-
tionnaires: (1) EQ-5D-3L questionnaire on general 
wellbeing, (2) Hospital Anxiety and Depression Scale 
(HADS) questionnaire on anxiety and depression 
[25, 26], and (3) Morisky Medication Adherence 
Scale (MMAS-8). Afterwards, 24h-ABPM was start-
ed. At the second visit (visit 2 — day 2) office BP 
was measured and tele-HBPM was initiated for one 
week. When the patient returned the HBPM-device 
(day 9) she/he had to fill in a questionnaire on the 
satisfaction concerning the type of BP measurement.
One month later the same examinations were re-
peated on the 3rd and 4th visit.
The study design is shown in Figure 1. 
Study sample
Untreated normotensive (NT) volunteers and treated 
hypertensive (HT) patients with or without CKD 
were recruited during the Nephrology & Hyperten-
sion outpatient clinic of the Universitair Ziekenhuis 
Brussel. 
To be eligible, participants had to be at least 18 
years old and had to sign the appropriate written in-
formed consent before any study-specific procedure 
was performed. Hypertensive patients had to be on 
a stable antihypertensive drug treatment.
Criteria for exclusion were: recent cardiovascular 
or cerebral event, severe HT (BP > 180/ > 110 mm 
Hg), atrial fibrillation, acute kidney failure, debilitat-
ing illness, pregnancy, impossibility to measure BP 
in a standardized way and any kind of disorder that 
compromises the ability of the subject to provide 
written informed consent and/or to comply with 
study procedures.
Blood pressure measurement
Blood pressure was measured according to the cur-
rent ESH/ESC guidelines [1], using a validated and 
calibrated device. For all types of BP measurement, 
the same cuff size was used around the non-domi-
nant arm or the non-fistula arm for haemodialysis 
patients.
Office BP was taken with an automated oscil-
lometric BP device (Omron HEM-705CP digital 
BP monitor, OMRON HEALTHCARE Co., Ltd. 
Kyoto, Japan), trice with a 1-minute interval, in 
sitting position, after 5 minutes of rest. The first of 
3 measurements was always excluded in the statisti-
cal analysis. Mean office BP in patients on dialysis 
(CKD stage 5) was calculated as the mean BP taken 
once before dialysis, every 30 minutes during dialysis 
and once after dialysis.
Ambulatory BP was recorded with oscillometric 
Space-Labs monitors (SpaceLabs Healthcare, Sno-
qualmie, Washington, USA). The devices were pro-
grammed to obtain BP readings at 15-minute inter-
vals from 08:00 to 22:00 and at 30-minute intervals 
for the remainder of the day. Afterwards, daytime 
and night-time ambulatory BP’s were calculated as 
the means of the readings obtained during actual 
awake and sleep time. 
For the self-measurement at home, the subjects 
used a validated upper-arm electronic automated 
sphygmomanometer, the Stabil-O-Graph mobil 
(IEM, GmBH, Stolberg, Germany) equipped for 
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BP telemonitoring. Patients measured their BP trice 
with a 1-minute interval in the morning and in the 
evening (between 06:00–10:00 and 18:00–22:00, re-
spectively) before eating and before taking any medi-
cation, during 7 consecutive days during the week 
immediately following the ABPM. Self-measured BP 
values were transmitted wireless by mobile phone 
to a website (VitalCare telemonitoring platform of 
Vitalsys, Antwerp, Belgium). All six measurements 
during the first day as well as every first measurement 
in the following sets of three measurements were 
excluded and mean tele-HBPM was calculated on 
the second and third measurement of each set from 
day 2 to day 7.
Definitions and hypertension control
Hypertension was defined as a mean office systolic 
BP (SBP) of at least 140 mm Hg and/or a mean 
office diastolic BP (DBP) of at least 90 mm Hg, or 
current treatment for hypertension. Blood pressure 
control for office BP was defined as a BP threshold 
< 140/< 90 mm Hg, for self-measured home BP < 
135/< 85 mm Hg, for ABPM < 135/< 85 mm Hg 
during daytime, < 120/< 70 mm Hg during sleep, 
and < 130/< 80 mm Hg for 24 h ABP. 
White coat effect (WCE) is defined as the condi-
tion in which BP is repeatedly elevated in the office 
and normal on out-of-office measurements; whereas 
masked hypertension is defined as normal office BP 
and elevated out-of-office measurements. 
Questionnaires
General wellbeing and psychological and emotional 
status of the subjects were analysed to evaluate if 
they would influence BP reproducibility, medication 
adherence and most of all satisfaction of the subjects 
with the different measurement techniques. 
Statistical analysis
Data were analysed with Statview, version 5.0.1 (SAS 
Institute Inc.) Statistics and Data Analysis Software 
and MedCalc for Windows, version 13.2.0.0 (Med-
Calc Software, Ostend, Belgium) [27]. Demographic 
and clinical disease characteristics were summarized. 
Blood pressure values and control rates were sum-
marized and compared, as well as global wellbeing, 
anxiety and depression, medication adherence and 
satisfaction concerning the type of BP measurement. 
For comparisons, Student’s t-test for continuous vari-
ables and chi-square-tests for categorical variables 
and proportions were used. 
The difference between the two different out-of-
office techniques was first explored by using a paired 
t-test and by calculating correlation coefficients, and 
secondly by the Bland-Altman-Method for multiple 
measurements [28, 29].
1 month “free”
1 week
tele-HBPM
1 week
tele-HBPM
24-ABPM 24-ABPM
V
is
it
 1
V
is
it
 2
V
is
it
 3
V
is
it
 4
Figure 1: Study design. 24h-ABPM — 24 h ambulatory blood pressure monitoring; tele-HBPM — telemedicine guided home blood 
pressure monitoring
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The study was conducted according to the Declara-
tion of Helsinki ethical principles for medical research 
involving human subjects. The study was approved by 
the Ethics committee of the Universitair Ziekenhuis 
Brussel (BUN 143201318660 — 30th Oct 2013) and 
written patient informed consent was obtained.
Results
Study sample
Baseline characteristics of the study population are 
given in Table 2. The study group included 16 NT 
volunteers, 18 patients with HT without CKD and 
23 patients with HT and CKD. Out of the 60 initially 
included patients, 3 patients withdrew before starting 
the study, 3 patients only participated once and with-
drew after the 2nd visit. Therefore, the data of these 
three patients, even as the data of one patient whose 
therapy was accidentally modified between visit 2 and 
visit 3, were excluded to compute reproducibility.
Blood pressure assessed by office BPM,  
24h-ABPM and tele-HBPM
Average BP values for each measuring method at all 
visits are given in Table 3 and Supplementary Table S1. 
Tele-HBP and 24h-ABPM showed very good repro-
ducibility as no significant differences were observed. 
On the other hand, mean office BP was significantly 
higher on the first two visits (133 ± 23 mm Hg) than 
on the last two visits (130 ± 17 mm Hg, p < 0.05). 
Low reproducibility of systolic OBP was mainly due 
to a considerably higher variability in patients with 
HT and CKD stage 5D (p = 0.035).
Mean tele-HBP showed no significant difference 
with daytime-ABP in the overall study population, 
but tele-systolic-HBP was significantly lower than 
systolic OBP on both occasions. 
The correlation coefficients between the two out-
of-office techniques were 0.748 and 0.702 for SBP 
and 0.705 and 0.752 for DBP on respectively the 
first and third visit (p < 0.0001). 
Bland-Altman-Plots for multiple measurements 
for SBP as well as for DBP showed good agreement 
between the two different out-of-office techniques, 
i.e. daytime-ABPM and tele-HBPM. Tele-systolic-
HBP was only 1.3 mm Hg lower than daytime-
systolic-ABP. Tele-diastolic-HBP was 0.3 mm Hg 
higher than daytime-diastolic-ABP (Fig. 2). 
BP control assessed by office BPM, 24h-ABPM 
and tele-HBPM
In the patients with HT, BP control rates ranged 
between 50.0% and 69.4% according to the tech- Ta
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nique used (Tab. 4 and Supplementary Tab. S2). 
During the second measurement week, significant 
more patients had better BP control. Blood pressure 
control assessed by tele-HBPM compared with day-
time-ABPM showed significant difference on both 
occasions (p = 0.0087 and 0.0235 on respectively 
the first and second measurement), although in the 
opposite direction.
The prevalence of WCE and masked hyperten-
sion in HT patients varied respectively between 
25.9–32.1% and 21.4–25.9% for tele-HBPM, and 
21.4–31.0% and 27.6–34.6% for daytime-ABPM.
Night-time hypertension was observed in 54.8% 
and 46.4% in patients with hypertension and in 0% 
and 7.1% in subjects not known with HT, respec-
tively on the first and second ABPM. 
Table 3. Overview of office blood pressure (BP), ambulatory BP and home BP
Blood pressure
Visit 1 + 2 Visit 3 + 4
SBP (mean ± SD) DBP (mean ± SD) SBP (mean ± SD) DBP (mean ± SD)
Office blood pressure [mm Hg] n = 57 n = 57 n = 52 n = 52
All patients 133.4 ± 22.6b, e 76.5 ± 12.2 129.8 ± 16.7*f 74.4 ± 11.1
Normotensive
Hypertensive without CKD
Hypertensive with CKD
CKD stage 3
CKD stage 4
CKD stage 5
126.3 ± 16.5
124.6 ± 18.8f
145.8 ± 24.1a,f
133.8 ± 12.3f
143.4 ± 15.2
151.5 ± 28.1b
71.5 ± 6.9
77.6 ± 15.5
79.5 ± 11.3
79.3 ± 8.3
77.1 ± 6.8
80.1 ± 13.4f
126.1 ± 18.8
124.0 ± 14.6f
136.4 ± 15.2*
128.7 ± 16.1
146.3 ± 14.6
137.6 ± 14.4*
71.1 ± 9.3
77.1 ± 11.7
74.3 ± 11.4*
78.3 ± 10.8
80.5 ± 12.7
71.0 ± 11.1*f
Daytime-ABP [mm Hg] n = 57 n = 57 n = 54 n = 54
All patients 129.1 ± 17.4d 77.7 ± 10.9 126.7 ± 14.0 75.4 ± 8.6*
Normotensive
Hypertensive without CKD
Hypertensive with CKD
CKD stage 3
CKD stage 4
CKD stage 5
123.7 ± 8.8
124.4 ± 17.2f
137.1 ± 19.4c
124.8 ± 8.8
141.0 ± 6.9
141.6 ± 22.5d
74.0 ± 9.2
79.4 ± 12.0f
79.0 ± 11.0
76.0 ± 6.5
81.0 ± 12.2
79.9 ± 12.7f
126.6 ± 13.6
121.8 ± 10.1
131.5 ± 15.2*
127.7 ± 12.9
140.7 ± 5.5
131.2 ± 17.4*
73.4 ± 7.0 
77.5 ± 8.4 
75.3 ± 9.6
76.5 ± 4.8
79.3 ± 8.7
73.8 ± 11.5*
Tele-HBP [mm Hg] n = 57 n = 57 n = 52 n = 52
All patients 127.7 ± 19.3c 77.3 ± 11.1 125.7 ± 13.8d 75.2 ± 8.5
Normotensive
Hypertensive without CKD
Hypertensive with CKD
CKD stage 3
CKD stage 4
CKD stage 5
124.9 ± 14.6
118.4 ± 13.9b,d
137.9 ± 21.2d
122.0 ± 12.0d
133.2 ± 6.1
146.7 ± 22.6
73.7 ± 4.9
76.1 ± 11.6b
80.9 ± 12.9
73.5 ± 8.7
75.2 ± 8.3
85.3 ± 13.7b,d
124.1 ± 12.6
118.8 ± 12.7d
132.9 ± 12.2
124.0 ± 8.8
136.3 ± 7.6
136.4 ± 12.9
72.5 ± 6.8
76.5 ± 9.6
76.4 ± 8.5
75.8 ± 4.8
78.2 ± 11.7
76.2 ± 9.8*d
ABP — ambulatory blood pressure; CKD — chronic kidney disease (CKD stage 3: eGFR (MDRD) 60–30 mL/min/1.73 m2; CKD stage 4: eGFR (MDRD) 30–15 mL/min/1.73 m2; CKD stage 5D: eGFR (MDRD) 
< 15 mL/min/1.73 m2); DBP — diastolic blood pressure; eGFR — estimated glomerular filtration rate; MDRD — modified diet renal disease; n — number of patients; SBP — systolic blood pressure; 
SD — standard deviation; tele-HBP — telemedicine-guided home blood pressure; *p < 0.05 compared to visit 1 + 2; ap < 0.005; bp < 0.05 compared to daytime-ABP; cp < 0.005; dp < 0.05 compared to office-BP; 
ep < 0.005; fp < 0.05 compared to tele-HBP
Figure 2: Bland-Altman-Plot for multiple measurements by tele-HBPM and daytime-ABPM; A — systolic blood pressure (SBP); 
B — diastolic blood pressure (DBP)
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Satisfaction with different types  
of out-of-office BP measurement
Study subjects overall preferred tele-HBPM over 
24h-ABPM (p < 0.0001 in the overall population 
on both occasions). Tele-HBPM had a score that 
was analogous with “satisfied”, whereas 24h-ABPM 
had a mean score analogous with “neither satisfied, 
neither unsatisfied”. This difference in preference 
was present in all patient groups without signifi-
cant difference in satisfaction amongst the different 
groups. 
Medication adherence and general wellbeing  
of the patient
The MMAS-8 value was 7.5 ± 0.9 and 7.6 ± 0.8 on 
respectively first and third visit, without significant 
differences between the different patient groups.
The overall study group scored in the normal 
range for HADS-anxiety and HADS-depression 
(Supplementary Figure S1) [25, 26]. Overall values 
for HADS-anxiety and HADS-depression were 3.8 
± 2.4 and 3.6 ± 2.7, and 4.4 ± 3.5 and 4.4 ± 4.2, 
both on respectively the first and third visit. The 
HADS-anxiety and HADS-depression values of the 
normotensive subjects were significantly better than 
those of the hypertensive patients. 
The visual analogue scale (VAS) showed an over-
all health status of 76.0% the first time and 73.9% 
the second time, with again a significant difference 
between NT subjects and hypertensive patients. Nor-
motensive subjects had a better health status as they 
scored better on every aspect of the EQ-5D descrip-
tive system on both occasions. Worst values were 
found in hypertensive patients with stage 5 CKD, on 
haemodialysis, on both visits.
Discussion
We observe a very good agreement between both 
out-of-office methods in NT volunteers, as well as in 
HT patients with or without CKD, with only a small 
systematic error between both measurements. Both 
out-of-office techniques show similar absolute BP 
values in a heterogeneous cohort of subjects with and 
without hypertension. We can therefore conclude 
that tele-HBPM is equivalent to ABPM for evaluat-
ing daytime SBP and DBP. Our results are in line 
with the data found by Mansoor et al. who also used 
tele-HBPM [21] and with the results of others, using 
HBPM with automatically stored readings (storage-
HBPM) and ABPM [13–17, 20–23]. However, very 
few studies have used tele-HBPM. 
Previous studies comparing conventional-HBPM 
and storage-HBPM revealed precise values in only 
68–76% of the cases in the manual logbook entries 
[7]. Tele-HBPM has the same advantages of manual 
registration of BP values, but improves data quality 
reporting, decreases the chance of false reporting 
by the patient, and makes interpretation by physi-
cians easier. Although there is no evidence so far for 
better results on long-term morbidity or mortality, 
tele-HBPM significantly increases compliance and 
BP control, and with a possible additional effect 
beyond conventional-HBPM [7, 30–38]. However, 
all meta-analysis concluded that the heterogeneity 
between studies in terms of intervention, technol-
ogy and study design makes it difficult to make firm 
conclusions [32, 38]. The telemonitoring-system has 
some disadvantages too, as it may be a complex 
procedure for some patients, and it is more expen-
sive compared to office BP measurements [31]. In 
Table 4. The proportion of hypertensive patients with controlled blood pressure (BP) and uncontrolled BP according to office BP, 
24 h ambulatory blood pressure (24h-ABPM) and telemedicine-guided home blood pressure (tele-HBPM)
BP measurement BP at goal (%) Uncontrolled SBP (%) Uncontrolled DBP (%) Uncontrolled SBP  and DBP (%)
Mean office BP
Visit 1 and 2
Visit 3 and 4
50.0
64.9*
39.4
27.0
2.6
0.0
7.9
8.1
Mean daytime-ABP
Daytime-ABPM 1
Daytime-ABPM 2
56.8
56.8*
21.6
24.3
2.7
10.8
18.9
8.1
Mean tele-HBP
Tele-HBPM 1
Tele-HBPM 2
55.6∆
69.4*∆ 
19.4
19.4
8.3
5.6
16.7
5.6
ABP — ambulatory blood pressure; BP — blood pressure; DBP — diastolic blood pressure; SBP — systolic blood pressure; tele-HBP — telemedicine guided home blood pressure; *p < 0.05 between visit 1 + 2  
and visit 3 + 4; ∆p < 0.05 between tele-HBPM and daytime ABPM, respectively on the first and second measurement
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contrast to 24h-ABPM, tele-HBPM doesn’t provide 
any information on night-time BP. In our cohort, 
the BP load, expressed as percentage of systolic/
diastolic readings ≥ 120/≥ 70 mm Hg and ≥ 135/≥ 
85 mm Hg during night and day, respectively, is 
significantly higher during night-time compared to 
daytime (49% vs. 43%) [39]. The latter emphasizes 
the importance of 24h-ABPM in assessing hyperten-
sive patients, as night-time-ABP has been suggested 
to be a more sensitive predictor of patients with 
higher CV-risk [1].
BP values are very similar between the two series 
of measurements, irrespective of the used BP mea-
surement technique, except in patients with CKD 
stage 5. This indicates that measuring and evaluating 
BP in patients on haemodialysis remains difficult, 
even with out-of-office devices, which corresponds 
with earlier publications, but without telemedicine 
[2, 40–42]. It also implies that measurements per-
formed according to a standardised manner as rec-
ommended by the guidelines, increases reproduc-
ibility and decreases the WCE [43–46]. 
In the hypertensive patients, intensive BP moni-
toring significantly increases BP control, irrespec-
tively of the technique used. These findings are in 
line with previous studies showing better BP control 
when patients have an intensive follow-up. [47–50]. 
Possible reasons for better BP control at the second 
intervention period could be: (1) Better medication 
adherence, although the MMAS-8-questionnaire 
reveals no significant difference between the first 
and second series of measurements. However this 
is a self-reported questionnaire and may be biased. 
Moreover since adherence is already very high the 
first time, obtaining significant changes in a small 
number of subjects is very hard; (2) Decrease in 
anxiousness and improvement in general wellbeing 
due to close monitoring. However, both question-
naires on general wellbeing do not reveal a decrease 
in anxiousness or depression; or (3) Habituation to 
the method which results in less stress on the mo-
ment of measurement and a better sleeping pattern 
during 24h-ABPM. 
Overall study subjects, regardless of their age, BP 
status, or kidney function are more satisfied with tele-
HBPM than 24h-ABPM. Lower satisfaction rates 
for 24h-ABPM may be explained by the frequency 
of preprogramed and additional BP measurements, 
taken when the arm is not held still or when there 
is a nod in the cable, shortening the measurement 
interval. The 24h-ABPM may also interfere with 
daily activities and disturb sleeping pattern. The lat-
ter is considered by several studies to be an important 
reason for dissatisfaction [51–53]. Furthermore pain, 
skin irritation and bruising are accounted responsible 
for lower satisfaction with ABPM [53].
In our overall study population the preference 
for further follow-up is tele-HBPM, regardless of 
their BP status or kidney function; but younger 
people (20’s to 50’s) are less unanimous. Although 
all younger people are also more satisfied with tele-
HBPM than 24h-ABPM, an equal part (50%) of 
them prefer tele-HBPM to 24h-ABPM for further 
follow-up compared to 70–80% of the elderly peo-
ple. The fact that younger people have less tendency 
to choose tele-HBPM for further follow-up may be 
explained by the assumption that on the one hand 
younger people are part of the working class and/or 
have young children to look after and consequently 
have less time. On the other hand elderly people are 
retired and do not mind spending some extra time 
on measuring BP thrice in the morning and in the 
evening. We think that these arguments surpass the 
greater satisfaction with tele-HBPM in their choice 
for further follow-up. 
Our study has several strengths. This is a pro-
spective study with three different BP measurement 
techniques in normotensive volunteers and in hyper-
tensive patients with and without CKD. The design 
is made in a way that we obtained several office 
BP values, measured according to the recommended 
guidelines and thereby increasing reproducibility and 
reliability. The same accounts for 24h-ABPM and 
tele-HBPM. 
On the other hand a limitation of this pilot study 
is the limited number of patients. Both tele-HBPM 
and 24h-ABPM have some constraints. We encoun-
tered several potential technical difficulties with tele-
HBPM, i.e. mistakes in the pre-set date of the device, 
a not fully charged or out of service mobile phone 
and an unannounced upgrade of the system by the 
responsible company whereby data were not auto-
matically transmitted. Tele-HBPM also asks a great 
participation of the patient. This may have positive 
effects on the awareness of her/his hypertensive sta-
tus, but it makes physicians also more dependent on 
the patients’ collaboration. Some patients had few 
measurements because they did not take the device 
with them when not returning home, they forgot 
to take their BP, or it was not compatible with their 
social life. It also requires very accurate explanation 
how to measure BP at home and transfer the data 
with a telemedicine-guided BPM device, which is 
time-consuming. 
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Conclusion
In summary, we can conclude that the effective-
ness of both out-of-office BP measuring techniques 
(telemedicine-guided HBP and daytime-ABP) in as-
sessing BP and BP control rates is very comparable 
in normotensive subjects as well as in HT patients 
without and with CKD. 
Out-of-office BPM techniques are the ones best 
used for further follow-up as they have better repro-
ducibility than office BP. Most patients are more sat-
isfied with tele-HBPM than with ABPM and prefer 
to have a follow-up by tele-HBPM rather than by 
24h-ABPM.
Tele-HBPM is a promising diagnostic and thera-
peutic tool, but long-term studies are needed to de-
termine the cost-effectiveness.
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